Research ExplorerPublicationsPO-31: The small-molecule FXIa inhibitor, BMS-26208, prevent...

PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression

Standard

PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression. / Mäder, J; Voigtländer, Minna; Rolling, C; Quick, H; Schulenkorf, A; Lehr, C; Bokemeyer, C; Beckmann, L; Langer, F.

In: THROMB RES, Vol. 213, No. Suppl 2, S25, 01.05.2022.

Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

Harvard

Mäder, J, Voigtländer, M, Rolling, C, Quick, H, Schulenkorf, A, Lehr, C, Bokemeyer, C, Beckmann, L & Langer, F 2022, 'PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression', THROMB RES, vol. 213, no. Suppl 2, S25. https://doi.org/10.1016/S0049-3848(22)00221-3

APA

Mäder, J., Voigtländer, M., Rolling, C., Quick, H., Schulenkorf, A., Lehr, C., Bokemeyer, C., Beckmann, L., & Langer, F. (2022). PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression. THROMB RES, 213(Suppl 2), [S25]. https://doi.org/10.1016/S0049-3848(22)00221-3

Vancouver

Mäder J, Voigtländer M, Rolling C, Quick H, Schulenkorf A, Lehr C et al. PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression. THROMB RES. 2022 May 1;213(Suppl 2). S25. https://doi.org/10.1016/S0049-3848(22)00221-3

Bibtex

@article{5ee1511c11d54b08bb479698f0b1157d,
title = "PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression",
author = "J M{\"a}der and Minna Voigtl{\"a}nder and C Rolling and H Quick and A Schulenkorf and C Lehr and C Bokemeyer and L Beckmann and F Langer",
note = "{\textcopyright} 2022 Elsevier Ltd. All rights reserved.",
year = "2022",
month = may,
day = "1",
doi = "10.1016/S0049-3848(22)00221-3",
language = "English",
volume = "213",
journal = "THROMB RES",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "Suppl 2",

}

RIS

TY - JOUR

T1 - PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression

AU - Mäder, J

AU - Voigtländer, Minna

AU - Rolling, C

AU - Quick, H

AU - Schulenkorf, A

AU - Lehr, C

AU - Bokemeyer, C

AU - Beckmann, L

AU - Langer, F

N1 - © 2022 Elsevier Ltd. All rights reserved.

PY - 2022/5/1

Y1 - 2022/5/1

U2 - 10.1016/S0049-3848(22)00221-3

DO - 10.1016/S0049-3848(22)00221-3

M3 - Conference abstract in journal

C2 - 35643672

VL - 213

JO - THROMB RES

JF - THROMB RES

SN - 0049-3848

IS - Suppl 2

M1 - S25

ER -